UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions
SHENZHEN, China, Aug. 19, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce a Memorandum of Understanding ("MOU") with XCardio, a Japanese company owned by Dr. Ehud Baron, a leader in medical technology innovation. This partnership focuses on the joint development of state-of-the-art continuous blood pressure monitoring devices, BPWatch, aimed at advancing cardiovascular...
Bone Index Announces Successful Financing Round and Strategic Partnership with Lynx Financial
KUOPIO, Finland, Aug. 20, 2024 /PRNewswire/ -- Bone Index Finland Ltd, a pioneering company in medical technology, proudly announces the completion of its latest financing round and a strategic partnership with Lynx Financial (HK) Limited. This partnership aims to enhance Bone Index's distribution and service capabilities in North America and Asia Pacific....
LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital
TOKYO, Aug. 29, 2024 /PRNewswire/ -- LOTTE Holdings Co., Ltd. ("LOTTE Holdings") is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital ("CVC") dedicated to investing in biopharmaceuticals and next-generation modalities. LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital LOTTE Group operates under the group...
LiveWell Awarded Frost & Sullivan’s 2024 Global Customer Value Leadership Award for Advancing Equitable and Accessible Mental Health Solutions
LiveWell's app integrates cutting-edge artificial intelligence (AI) and machine learning to provide personalized mental and behavioral health support, fostering user engagement across 27 countries and 9 languages. SAN ANTONIO, Sept. 27, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the mental and behavioral health industry and, based on its findings, recognizes LiveWell by Zurich (LiveWell) with the 2024 Global...
Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients
SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that, through the "Hong Kong and Macau Medicine and Equipment Connect" policy, VELSIPITY® has officially been approved for patients with moderately to severely active ulcerative colitis (UC) by the...
I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population
More than 100 million people in the US have this HLA-A haplotype PALO ALTO, Calif., Oct. 30, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the company has successfully generated iPS cell lines that are homozygous...
GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025
YONGIN, South Korea , Feb. 11, 2025 /PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, held from Feb. 3rd to 7th, 2025, in San Diego, USA. WORLD Symposium 2025 is an international...
Singapore’s Best Workplaces in Healthcare & Biopharma™ 2025 Announced, Showcasing Insights from Nearly 10,000 Employees
SINGAPORE, March 26, 2025 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture, has officially announced Singapore's Best Workplaces in Healthcare & Biopharma™ 2025 list, celebrating 10 pioneering healthcare and biopharma companies that have created exceptional workplace cultures. Now in its third year since the list's inaugural launch, this recognition...
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 SINGAPORE, July 29, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero...
Kinseed Selects Solace’s Event Streaming and Management Solution to Accelerate Digital Transformation in the Healthcare Industry
Leading healthcare IT provider revolutionizing the patient data journey with event-driven architecture LONDON, Nov. 23, 2022 /PRNewswire/ -- Solace, the leading enabler of event-driven architecture (EDA) for real-time enterprises, announced today that UK-based Kinseed is using Solace's event streaming and management solution, PubSub+ Platform, to improve and expand the real-time data distribution...
